Core Insights - Veeva Systems has announced that over 125 customers, including multiple top 20 biopharmaceutical companies, are now utilizing Veeva Vault CRM, marking a significant step in the industry's transition to agentic CRM [1][1][1] - The success of Vault CRM is attributed to its comprehensive industry and regional functionalities, compliance, workflows, and support for complex customer engagements throughout the product lifecycle [1][1] - Veeva has updated the end-of-support date for Veeva CRM from September 2030 to December 2029, indicating a commitment to ongoing product support and innovation [1][1] Company Overview - Veeva Systems provides cloud-based software, data, and business consulting services specifically for the life sciences industry, serving over 1,500 customers ranging from large biopharmaceutical firms to emerging biotech companies [1][1] - The Vault CRM Suite includes various applications such as Events Management, Service Center, Campaign Manager, and Patient CRM, designed to enhance commercial execution for biopharma companies [1][1] Industry Impact - The introduction of Veeva AI alongside Vault CRM is expected to further accelerate the industry's shift towards agentic customer engagement, highlighting the growing importance of technology in life sciences [1][1] - Veeva's focus on customer success and product excellence is driving its expansion and influence across the life sciences sector [1][1]

Company Overview - Veeva Systems Inc. announced Veeva CRM Pulse, a data subscription service providing quarterly healthcare professional access and multichannel engagement metrics for the life sciences industry [1] - The service is currently available for Veeva's CRM customers, covering 2024 quarterly data across multiple countries including the US, Canada, and several European and Asian nations [2] - The introduction of CRM Pulse is expected to significantly enhance the Veeva Data Cloud product category, thereby boosting overall business performance [3] Financial Performance - Following the announcement of CRM Pulse, Veeva's shares increased by nearly 7.9% [4] - The company has a market capitalization of $38.34 billion and an earnings yield of 2.9%, which is favorable compared to the industry's negative yield [5] - In the last reported quarter, Veeva delivered an earnings surprise of 10.1% [5] Strategic Significance - Management believes that CRM Pulse will improve global segmentation and targeting, enhancing the value of data for commercial operations [6] - The latest availability of healthcare professional access data is seen as a significant milestone for Veeva Systems, expected to boost its business [8] Industry Prospects - The global healthcare analytics market was valued at $43.1 billion in 2023 and is projected to grow at a CAGR of 21.1% from 2024 to 2030, driven by technological advancements and the need for improved patient care [7]